
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.5B | $4B | $3.7B | $3.9B | $4B | |
Revenue Growth (YoY) | 2.71% | 59.9% | -5.51% | 3.42% | 3.54% | |
Cost of Revenues | $708.7M | $1B | $1.1B | $1.2B | $1.2B | |
Gross Profit | $1.8B | $2.9B | $2.6B | $2.7B | $2.8B | |
Gross Profit Margin | 71.33% | 74.26% | 70.52% | 70.09% | 70% | |
R&D Expenses | $175.3M | $250.3M | $305.3M | $346.8M | $364.2M | |
Selling, General & Admin | $1.2B | $1.7B | $1.7B | $1.7B | $1.8B | |
Other Inc / (Exp) | -$11.3M | $32.9M | -$60.4M | -$32.7M | -$83M | |
Operating Expenses | $1.4B | $2B | $2B | $2.1B | $2.1B | |
Operating Income | $387.2M | $976.4M | $654M | $656.7M | $671.8M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $378.9M | $1B | $599.1M | $641.2M | $609M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.4B | $240.4M | $237.5M | $196.2M | $187.6M | |
Net Income to Company | $1.8B | $772M | $361.6M | $445.1M | $421.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.8B | $772M | $361.6M | $445.1M | $421.4M | |
Basic EPS (Cont. Ops) | $22.55 | $9.78 | $4.62 | $5.82 | $5.63 | |
Diluted EPS (Cont. Ops) | $22.41 | $9.69 | $4.61 | $5.81 | $5.62 | |
Weighted Average Basic Share | $78.8M | $78.9M | $78.2M | $76.4M | $74.9M | |
Weighted Average Diluted Share | $79.2M | $79.7M | $78.4M | $76.6M | $75M | |
EBITDA | $480.7M | $1.1B | $779.8M | $799.1M | $816.8M | |
EBIT | $387.2M | $976.4M | $654M | $656.7M | $671.8M | |
Revenue (Reported) | $2.5B | $4B | $3.7B | $3.9B | $4B | |
Operating Income (Reported) | $387.2M | $976.4M | $654M | $656.7M | $671.8M | |
Operating Income (Adjusted) | $387.2M | $976.4M | $654M | $656.7M | $671.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $894.8M | $973.2M | $943.1M | $997.4M | $979.3M | |
Revenue Growth (YoY) | 62.4% | 8.77% | -3.09% | 5.76% | -1.82% | |
Cost of Revenues | $217.7M | $263.9M | $282.5M | $299.6M | $299.2M | |
Gross Profit | $677.1M | $709.3M | $660.7M | $697.8M | $680.1M | |
Gross Profit Margin | 75.67% | 72.89% | 70.05% | 69.96% | 69.45% | |
R&D Expenses | $54.5M | $71.8M | $87.4M | $91.9M | $97.2M | |
Selling, General & Admin | $397.1M | $439.5M | $439.7M | $451.8M | $447.6M | |
Other Inc / (Exp) | $34.5M | -$11.3M | -$1.2M | -$141K | -$152K | |
Operating Expenses | $451.7M | $511.3M | $527.1M | $543.7M | $544.8M | |
Operating Income | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $261.6M | $187.5M | $134.6M | $158.4M | $140.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $61.2M | $53.2M | $46.8M | $53.4M | $47.2M | |
Net Income to Company | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
Basic EPS (Cont. Ops) | $2.54 | $1.71 | $1.14 | $1.40 | $1.27 | |
Diluted EPS (Cont. Ops) | $2.51 | $1.70 | $1.14 | $1.39 | $1.27 | |
Weighted Average Basic Share | $79M | $78.7M | $76.9M | $75.2M | $73.6M | |
Weighted Average Diluted Share | $79.8M | $79.2M | $77.1M | $75.3M | $73.6M | |
EBITDA | $251.1M | $227.7M | $169.3M | $187.1M | $174.4M | |
EBIT | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
Revenue (Reported) | $894.8M | $973.2M | $943.1M | $997.4M | $979.3M | |
Operating Income (Reported) | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
Operating Income (Adjusted) | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.8B | $4B | $3.7B | $3.9B | $4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $769.8M | $1.1B | $1.1B | $1.2B | $1.2B | |
Gross Profit | $2B | $3B | $2.6B | $2.7B | $2.8B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $188.3M | $267.6M | $320.9M | $351.2M | $369.5M | |
Selling, General & Admin | $1.3B | $1.8B | $1.7B | $1.7B | $1.8B | |
Other Inc / (Exp) | $41.7M | -$12.9M | -$50.3M | -$31.6M | -$83M | |
Operating Expenses | $1.5B | $2B | $2B | $2.1B | $2.1B | |
Operating Income | $542.7M | $949M | $589.5M | $677.3M | $652.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $587.2M | $938.3M | $546.2M | $665M | $591M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $129.1M | $232.3M | $231.1M | $202.7M | $181.5M | |
Net Income to Company | $458.1M | $705.9M | $315.1M | $462.3M | $409.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $458.1M | $705.9M | $315.1M | $462.3M | $409.6M | |
Basic EPS (Cont. Ops) | $5.81 | $8.95 | $4.05 | $6.09 | $5.49 | |
Diluted EPS (Cont. Ops) | $5.75 | $8.89 | $4.05 | $6.07 | $5.49 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $641.1M | $1.1B | $721.5M | $816.8M | $804.1M | |
EBIT | $542.7M | $949M | $589.5M | $677.3M | $652.9M | |
Revenue (Reported) | $2.8B | $4B | $3.7B | $3.9B | $4B | |
Operating Income (Reported) | $542.7M | $949M | $589.5M | $677.3M | $652.9M | |
Operating Income (Adjusted) | $542.7M | $949M | $589.5M | $677.3M | $652.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $894.8M | $973.2M | $943.1M | $997.4M | $979.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $217.7M | $263.9M | $282.5M | $299.6M | $299.2M | |
Gross Profit | $677.1M | $709.3M | $660.7M | $697.8M | $680.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $54.5M | $71.8M | $87.4M | $91.9M | $97.2M | |
Selling, General & Admin | $397.1M | $439.5M | $439.7M | $451.8M | $447.6M | |
Other Inc / (Exp) | $34.5M | -$11.3M | -$1.2M | -$141K | -$152K | |
Operating Expenses | $451.7M | $511.3M | $527.1M | $543.7M | $544.8M | |
Operating Income | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $261.6M | $187.5M | $134.6M | $158.4M | $140.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $61.2M | $53.2M | $46.8M | $53.4M | $47.2M | |
Net Income to Company | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
Basic EPS (Cont. Ops) | $2.54 | $1.71 | $1.14 | $1.40 | $1.27 | |
Diluted EPS (Cont. Ops) | $2.51 | $1.70 | $1.14 | $1.39 | $1.27 | |
Weighted Average Basic Share | $79M | $78.7M | $76.9M | $75.2M | $73.6M | |
Weighted Average Diluted Share | $79.8M | $79.2M | $77.1M | $75.3M | $73.6M | |
EBITDA | $251.1M | $227.7M | $169.3M | $187.1M | $174.4M | |
EBIT | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
Revenue (Reported) | $894.8M | $973.2M | $943.1M | $997.4M | $979.3M | |
Operating Income (Reported) | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
Operating Income (Adjusted) | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $960.8M | $1.1B | $942.1M | $937.4M | $1B | |
Short Term Investments | -- | $72M | $57.5M | $35.3M | -- | |
Accounts Receivable, Net | $657.7M | $897.2M | $859.7M | $903.4M | $995.7M | |
Inventory | $139.2M | $230.2M | $338.8M | $296.9M | $254.3M | |
Prepaid Expenses | $30.1M | $70.2M | $69.1M | $52.5M | $83M | |
Other Current Assets | $61.7M | $31.5M | $16.8M | $77.3M | $81.6M | |
Total Current Assets | $1.8B | $2.5B | $2.4B | $2.4B | $2.5B | |
Property Plant And Equipment | $817.3M | $1.2B | $1.4B | $1.4B | $1.4B | |
Long-Term Investments | -- | $125.3M | $42M | $8M | -- | |
Goodwill | $444.8M | $418.5M | $407.6M | $419.5M | $442.6M | |
Other Intangibles | $130.1M | $109.7M | $95.7M | $82.1M | $103.5M | |
Other Long-Term Assets | $35.2M | $57.5M | $55.8M | $128.7M | $234.2M | |
Total Assets | $4.8B | $5.9B | $5.9B | $6.1B | $6.2B | |
Accounts Payable | $142.1M | $163.9M | $127.9M | $113.1M | $108.7M | |
Accrued Expenses | $353.7M | $550.8M | $353.5M | $458M | $518.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $21.7M | $22.7M | $26.6M | $29.7M | $31.1M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.3B | $1.9B | $1.9B | $2.1B | $2B | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.6B | $2.3B | $2.3B | $2.5B | $2.4B | |
Common Stock | $8K | $8K | $8K | $7K | $7K | |
Other Common Equity Adj | $43.5M | $4.3M | -$10.3M | $21.2M | $6M | |
Common Equity | $3.2B | $3.6B | $3.6B | $3.6B | $3.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $3.2B | $3.6B | $3.6B | $3.6B | $3.9B | |
Total Liabilities and Equity | $4.8B | $5.9B | $5.9B | $6.1B | $6.2B | |
Cash and Short Terms | $960.8M | $1.2B | $999.6M | $972.7M | $1B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.1B | $926.1M | $832.4M | $865.8M | $873M | |
Short Term Investments | -- | $86.7M | $51.6M | $33.1M | -- | |
Accounts Receivable, Net | $719M | $950.9M | $884.4M | $950.7M | $1.1B | |
Inventory | $150.6M | $275.7M | $311.9M | $280.1M | $246.6M | |
Prepaid Expenses | -- | $74.1M | $84.4M | $72.2M | $104.1M | |
Other Current Assets | $114.3M | $32.3M | $22.5M | $70.5M | $83.2M | |
Total Current Assets | $2.1B | $2.5B | $2.3B | $2.5B | $2.4B | |
Property Plant And Equipment | $846.3M | $1.3B | $1.4B | $1.4B | $1.4B | |
Long-Term Investments | -- | $107.7M | $37.4M | $3.6M | -- | |
Goodwill | $427.6M | $412M | $414.2M | $458.2M | $457.6M | |
Other Intangibles | $120.5M | $103.5M | $93.3M | $121.4M | $102.8M | |
Other Long-Term Assets | $38M | $57.7M | $54.3M | $121.8M | $238.9M | |
Total Assets | $5.1B | $5.9B | $5.9B | $6.2B | $6.1B | |
Accounts Payable | $124.3M | $186.5M | $130.6M | $117.2M | $125.4M | |
Accrued Expenses | $343.6M | $394.2M | $364.4M | $426.3M | $466.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $21.5M | $25.2M | $27.8M | $31.3M | $32M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.4B | $1.9B | $2B | $2B | $2B | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.7B | $2.3B | $2.4B | $2.4B | $2.3B | |
Common Stock | $8K | $8K | $8K | $7K | $7K | |
Other Common Equity Adj | $29M | -$5.7M | $1.8M | $18.4M | $18.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $3.4B | $3.7B | $3.5B | $3.8B | $3.8B | |
Total Liabilities and Equity | $5.1B | $5.9B | $5.9B | $6.2B | $6.1B | |
Cash and Short Terms | $1.1B | $1B | $884M | $898.9M | $873M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.8B | $772M | $361.6M | $445.1M | $421.4M | |
Depreciation & Amoritzation | $93.5M | $108.7M | $125.8M | $142.4M | $145M | |
Stock-Based Compensation | $98.4M | $114.3M | $133.4M | $154M | $173.7M | |
Change in Accounts Receivable | -$139.8M | -$262.1M | $21.5M | -$104.6M | -$153.5M | |
Change in Inventories | -$29.1M | -$112.5M | -$130.1M | $30.2M | $25.1M | |
Cash From Operations | $662.2M | $1.2B | $568.7M | $785.8M | $738.2M | |
Capital Expenditures | $154.9M | $401.1M | $291.9M | $177.7M | $115.6M | |
Cash Acquisitions | -$420.8M | -$8M | -$12.3M | -$77M | -$183.4M | |
Cash From Investing | -$231.5M | -$563.4M | -$213.3M | -$195.9M | -$254.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$375M | -$435M | -$592.4M | -$352.9M | |
Other Financing Activities | -$51.1M | -$108.9M | -$92.8M | -$32.6M | -$28.1M | |
Cash From Financing | -$30.8M | -$458.3M | -$501.7M | -$598.3M | -$355.7M | |
Beginning Cash (CF) | $551.1M | $961.5M | $1.1B | $942.4M | $938.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $399.9M | $150.8M | -$146.3M | -$8.5M | $127.6M | |
Ending Cash (CF) | $961.5M | $1.1B | $942.4M | $938.5M | $1B | |
Levered Free Cash Flow | $507.3M | $771.4M | $276.8M | $608.1M | $622.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
Depreciation & Amoritzation | $25.6M | $29.6M | $35.8M | $32.9M | $39.1M | |
Stock-Based Compensation | $27.2M | $31.6M | $37.7M | $38.8M | $45M | |
Change in Accounts Receivable | -$67.4M | -$55.5M | -$32.7M | -$69.6M | -$65.3M | |
Change in Inventories | -$15.6M | -$49.5M | $24M | $15.6M | $7.4M | |
Cash From Operations | $227.2M | $30.5M | $199.9M | $28.7M | $52.7M | |
Capital Expenditures | $43.4M | $87.3M | $64.1M | $9.4M | $25.3M | |
Cash Acquisitions | -- | -- | -- | -$77.1M | -- | |
Cash From Investing | $4.6M | -$90.2M | -$52.8M | -$79.6M | -$25.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$75M | -$292.4M | -- | -$201.1M | |
Other Financing Activities | -$66.6M | -$51.5M | $19.1M | -$26.1M | -$19.6M | |
Cash From Financing | -$53.4M | -$111.7M | -$259M | -$11.7M | -$206.8M | |
Beginning Cash (CF) | $961.5M | $1.1B | $942.4M | $938.5M | $1B | |
Foreign Exchange Rate Adjustment | -$7.5M | -$1.8M | $2.2M | -$9M | $8.5M | |
Additions / Reductions | $178.3M | -$171.4M | -$111.9M | -$62.6M | -$179.4M | |
Ending Cash (CF) | $1.1B | $926.9M | $832.7M | $866.9M | $874.1M | |
Levered Free Cash Flow | $183.8M | -$56.8M | $135.8M | $19.3M | $27.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $458.1M | $705.9M | $315.1M | $462.3M | $409.6M | |
Depreciation & Amoritzation | $98.4M | $112.7M | $132M | $139.5M | $151.2M | |
Stock-Based Compensation | $102.7M | $118.7M | $139.5M | $155.1M | $179.9M | |
Change in Accounts Receivable | -$221M | -$250.2M | $44.4M | -$141.5M | -$149.2M | |
Change in Inventories | -$34.2M | -$146.3M | -$56.6M | $21.7M | $16.9M | |
Cash From Operations | $879.6M | $975.9M | $738.1M | $614.5M | $762.2M | |
Capital Expenditures | $152.3M | $445M | $268.7M | $123M | $131.5M | |
Cash Acquisitions | -$420.8M | -$8M | -$12.3M | -$154.1M | -$106.3M | |
Cash From Investing | -$503.2M | -$658.2M | -$175.9M | -$222.7M | -$200.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$450.1M | -$652.4M | -$300M | -$554M | |
Other Financing Activities | -$72.3M | -$93.9M | -$22.1M | -$77.8M | -$21.6M | |
Cash From Financing | -$49.5M | -$516.6M | -$648.9M | -$351.1M | -$550.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $326.9M | -$199M | -$86.7M | $40.8M | $10.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $727.3M | $530.9M | $469.4M | $491.6M | $630.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
Depreciation & Amoritzation | $25.6M | $29.6M | $35.8M | $32.9M | $39.1M | |
Stock-Based Compensation | $27.2M | $31.6M | $37.7M | $38.8M | $45M | |
Change in Accounts Receivable | -$67.4M | -$55.5M | -$32.7M | -$69.6M | -$65.3M | |
Change in Inventories | -$15.6M | -$49.5M | $24M | $15.6M | $7.4M | |
Cash From Operations | $227.2M | $30.5M | $199.9M | $28.7M | $52.7M | |
Capital Expenditures | $43.4M | $87.3M | $64.1M | $9.4M | $25.3M | |
Cash Acquisitions | -- | -- | -- | -$77.1M | -- | |
Cash From Investing | $4.6M | -$90.2M | -$52.8M | -$79.6M | -$25.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$75M | -$292.4M | -- | -$201.1M | |
Other Financing Activities | -$66.6M | -$51.5M | $19.1M | -$26.1M | -$19.6M | |
Cash From Financing | -$53.4M | -$111.7M | -$259M | -$11.7M | -$206.8M | |
Beginning Cash (CF) | $961.5M | $1.1B | $942.4M | $938.5M | $1B | |
Foreign Exchange Rate Adjustment | -$7.5M | -$1.8M | $2.2M | -$9M | $8.5M | |
Additions / Reductions | $178.3M | -$171.4M | -$111.9M | -$62.6M | -$179.4M | |
Ending Cash (CF) | $1.1B | $926.9M | $832.7M | $866.9M | $874.1M | |
Levered Free Cash Flow | $183.8M | -$56.8M | $135.8M | $19.3M | $27.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.